News Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
4.27 ^USD	-0.23%		-2.51%	-14.77%

May. 30	Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target	MT
May. 16	Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	Jun. 07	PR
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Jun. 03	AQ
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers	Jun. 03	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	May. 30	PR
Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target	May. 30	MT
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference	May. 28	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	May. 23	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	May. 16	PR
Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating	May. 16	MT
Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024	May. 15
Abeona Therapeutics: Q1 Earnings Snapshot	May. 15	AQ
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress	May. 15	AQ
Abeona Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	May. 07	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO	May. 06	PR
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants	May. 06	AQ
Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise	May. 03	MT
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants	May. 03	AQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors	May. 02	BU
Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors	May. 01	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Abeona Therapeutics Inc.

Equities

ABEO

US00289Y2063

Summary

Filters